[{"Assets_0_Q2_USD":129627000.0,"CommonStockSharesOutstanding_0_Q2_shares":33173000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-25443000.0,"NetIncomeLoss_1_Q2_USD":-14739000.0,"NetIncomeLoss_2_Q2_USD":-29343000.0,"StockholdersEquity_0_Q2_USD":112397000.0,"Ticker":"KURA","CIK":"1422143","name":"KURA ONCOLOGY, INC.","OfficialName":"Kura Oncology Inc. Common Stock","form":"10-Q","period":"20180630","fy":"2018.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1071823749.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20180806"}]